Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCRPC (metastatic Castration-resistant Prostate Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05369000
What this trial is testing

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Lava Therapeutics 96
Not applicableNo Longer AvailableNCT04825652
What this trial is testing

177Lu-PSMA-617 Managed Access Program for mCRPC Patients

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Advanced Accelerator Applications
Not applicableStudy completedNCT03075735
What this trial is testing

Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)

Who this might be right for
Prostate Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 408
Post-approval studies (Phase 4)Study completedNCT03641560
What this trial is testing

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Inc 52
Testing effectiveness (Phase 2)Study completedNCT01360840
What this trial is testing

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
EMD Serono 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05658003
What this trial is testing

A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 63
Early research (Phase 1)Looking for participantsNCT07537010
What this trial is testing

3D1015 Injection for Patients With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, mCRPC
Chunjing Yu 8
Testing effectiveness (Phase 2)Study completedNCT03248570
What this trial is testing

Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects

Who this might be right for
Castration Resistant Prostatic CancerMetastatic Prostate Cancer
University of California, San Francisco 26
Early research (Phase 1)Looking for participantsNCT07813637
What this trial is testing

Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC

Who this might be right for
Prostate CancerCastration-Resistant Prostate Cancer (CRPC)Metastatic Prostate Cancer+1 more
Janux Therapeutics 110
Testing effectiveness (Phase 2)Looking for participantsNCT06785636
What this trial is testing

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)Prostate Cancer
Pathos AI, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT04631744
What this trial is testing

Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 4
Not applicableLooking for participantsNCT06828263
What this trial is testing

Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic Disease
University Hospital, Grenoble 130
Testing effectiveness (Phase 2)Looking for participantsNCT07476001
What this trial is testing

Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 12
Testing effectiveness (Phase 2)Ended earlyNCT01994590
What this trial is testing

Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT05553639
What this trial is testing

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Hookipa Biotech GmbH 12
Large-scale testing (Phase 3)Study completedNCT04887506
What this trial is testing

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Castration-sensitive Prostate CancerMetastatic Prostate Cancer
Tavanta Therapeutics 107
Early research (Phase 1)Ended earlyNCT02744287
What this trial is testing

Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Prostate Cancer
Regeneron Pharmaceuticals 52
Testing effectiveness (Phase 2)Looking for participantsNCT06353386
What this trial is testing

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Merck Sharp & Dohme LLC 220
Early research (Phase 1)Looking for participantsNCT07244341
What this trial is testing

Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Daiichi Sankyo 60
Not applicableLooking for participantsNCT07118436
What this trial is testing

Liquid Biopsy Under PSMA Radioligand Therapy

Who this might be right for
Prostate Cancer Metastatic Castration-ResistantProstate Cancer
Wuerzburg University Hospital 100
Next Page